title: Argyrophil cell density in the oxyntic mucosa is higher in female than in male morbidly obese patients.
abstract: Obesity is a multifactorial disorder often associated with many important diseases such as diabetes, hypertension and other metabolic syndrome conditions. Argyrophil cells represent almost the total population of endocrine cells of the human gastric mucosa and some reports have described changes of specific types of these cells in patients with obesity and metabolic syndrome. The present study was designed to evaluate the global population of argyrophil cells of the gastric mucosa of morbidly obese and dyspeptic non-obese patients. Gastric biopsies of antropyloric and oxyntic mucosa were obtained from 50 morbidly obese patients (BMI >40) and 50 non-obese patients (17 dyspeptic overweight and 33 lean individuals) and processed for histology and Grimelius staining for argyrophil cell demonstration. Argyrophil cell density in the oxyntic mucosa of morbidly obese patients was higher in female (238.68 ± 83.71 cells/mm(2)) than in male patients (179.31 ± 85.96 cells/mm(2)) and also higher in female (214.20 ± 50.38 cells/mm(2)) than in male (141.90 ± 61.22 cells/mm(2)) morbidly obese patients with metabolic syndrome (P = 0.01 and P = 0.02, respectively). In antropyloric mucosa, the main difference in argyrophil cell density was observed between female morbidly obese patients with (167.00 ± 69.30 cells/mm(2)) and without (234.00 ± 69.54 cells/mm(2)) metabolic syndrome (P = 0.001). In conclusion, the present results show that the number of gastric argyrophil cells could be under gender influence in patients with morbid obesity. In addition, gastric argyrophil cells seem to behave differently among female morbidly obese patients with and without metabolic syndrome.
authors.affiliation: Laboratório de Patologia Digestiva e Neuroendócrina, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brasil.
authors.forename: F A N
authors.initials: FA
authors.lastname: Maksud
authors.forename: A M
authors.initials: AM
authors.lastname: Kakehasi
authors.forename: A J A
authors.initials: AJ
authors.lastname: Barbosa
mesh_terms: D000328:Adult; D001706:Biopsy; D016022:Case-Control Studies; D002452:Cell Count; D019858:Enteroendocrine Cells / Q000473:pathology*; D005260:Female; D005753:Gastric Mucosa / Q000473:pathology*; D006801:Humans; D008297:Male; D024821:Metabolic Syndrome / Q000473:pathology*; D009767:Obesity, Morbid / Q000473:pathology*; D012737:Sex Factors
references.citation: Acta Soc Med Ups. 1968;73(5-6):243-70
references.pmid: 4185638
references.citation: Invest Cell Pathol. 1980 Jan-Mar;3(1):3-12
references.pmid: 6156147
references.citation: Acta Gastroenterol Belg. 1993 Jan-Feb;56(1):11-7
references.pmid: 7688175
references.citation: Circulation. 2004 Jan 27;109(3):433-8
references.pmid: 14744958
references.citation: Nutrition. 2000 Oct;16(10):924-36
references.pmid: 11054598
references.citation: Diabetes Metab Syndr Obes. 2012;5:75-87
references.pmid: 22570558
references.citation: Braz J Med Biol Res. 1997 Dec;30(12):1391-405
references.pmid: 9686157
references.citation: Regul Pept. 2000 Sep 25;93(1-3):31-5
references.pmid: 11033050
references.citation: J Physiol Pharmacol. 2007 Mar;58 Suppl 1:13-35
references.pmid: 17443025
references.citation: J Clin Endocrinol Metab. 2001 Oct;86(10):4753-8
references.pmid: 11600536
references.citation: Gastroenterology. 1997 Mar;112(3):707-17
references.pmid: 9041231
references.citation: Cancer. 2005 Jun 15;103(12):2643-53
references.pmid: 15864814
references.citation: Biomed Pharmacother. 2007 Feb-Apr;61(2-3):137-41
references.pmid: 17258885
references.citation: Gut. 1994 Feb;35(2):275-7
references.pmid: 8307483
references.citation: Eur J Endocrinol. 2011 Jul;165(1):57-62
references.pmid: 21558140